ESTIKAN 20MG 14 TAB; escitalopram, antidepressants .
ACTIVE-INGREDIENT OF ESTIKAN 20MG 14 TAB
ESTIKAN 20MG 14 TAB. Each film coated tablet contains 20 mg escitalopram ( as oxalate ).
INDICATION OF ESTIKAN 20MG 14 TAB
- Treatment of major depressive episodes.
- panic disorder with or without agoraphobia.
- social anxiety disorder (social phobia).
- generalised anxiety disorder.
- obsessive-compulsive disorder.
DOSAGE OF ESTIKAN 20MG 14 TAB
Follow all directions given to you by your pharmacist or doctor carefully . They may differ from the information contained in this leaflet
Ask your pharmacist or doctor for help if you do not understand the instructions on the box .
The recommended dose is : –
Maximum dose for adults under 65 years is 20 mg per day.
10 mg per day is the maximum recommended dose for patients with hepatic impairment, who are greater than 65 years of age.
Estikan is administered as a single daily dose and may be taken with or without food.
Maximum effectiveness is reached after about 3 months. The treatment lasts several months. Social anxiety disorder: Usual dosage is 10 mg once daily.
Usually 2-4 weeks are necessary to obtain symptom relief. Long-term treatment of responders has been studied for 6 months and can be considered on an individual basis to prevent relapse; treatment benefits should be re-evaluated at regular intervals.
Generalized anxiety disorder:
Initial dosage is 10 mg once daily. Depending on individual patient response, the dose may be increased to a maximum of 20 mg daily.
Obsessive-compulsive disorder: Initial dosage is 10 mg once daily. Depending on individual patient response, the dose may be increased to a maximum of 20 mg daily.
As OCD is a chronic disease, patients should be treated for a sufficient period to ensure that they are symptom free.
Elderly patients (> 65 years of age):
Initial treatment with half the usually recommended dose and a lower maximum dose should be considered. The efficiency of Estikan is social anxiety disorder has not been studied in elderly patients.
Children and adolescents ( < 18 years):
Estikan should not be used in the treatment of children and adolescents under the age of 18 years. Reduced renal function: Dosage adjustment is not necessary in patients with mild or moderate renal impairment.
OVER-DOSAGE OF ESTIKAN 20MG 14 TAB
Toxicity : Clinical data on escitalopram overdose are limited and many cases involve concomitant overedoses of other drugs. In the majority of cases mild or no symptoms have been reported. the majority of cases have involved overdose with concomitant medications. Doses between 400 and 800 mg of escitalopram alone have been taken without any severe symptoms.
symptoms seen in reported overdose of escitalopram include symptoms mainly related to central nervous system ( ranging from dizziness, tremor, and agitation to rare cases of serotonin syndrome, convulsion, and coma ). the gastrointestinal system (nausea/vomiting), and the cardiovascular system (hypotension, tachycardia, QT prolongation, and arrhythmia) and electrolyte/fluid balance conditions ( hypokalaemia, hypoatraemia ).
There is no specific antidote. Establish and maintain an airway, ensure adequate oxygenation and respiratory function.
Hypersensitivity to escitalopram or to any other of the ecipients.
Store at room temperature ( 25 °C ) or below. Keep out of the reach of children.
PACK OF ESTIKAN 20MG 14 TAB
A carton box containing 2 strips each strip contains 7 tablets and an insert.
ESTIKAN 20MG 14 TAB MANUFACTURED BY
Hikma Pharma S.A.E, sixth of October City-Egypt.